☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
hematology
Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)
March 2, 2021
Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics
February 11, 2021
BMS Signs an Exclusive Worldwide License Agreement with Dragonfly Therapeutics for DF6002
August 17, 2020
Sobi Acquires Novimmune's Emapalumab with its All Related Assets to Strengthen its Focus in Hematology and Immunology
June 13, 2019
Xoma Purchases Royalty Rights for Aronora's Five Preclinical and Clinical Hematology Candidates
April 8, 2019
Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio
February 6, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.